Garofalo Health Care Stock Fundamentals

GHC Stock  EUR 5.26  0.06  1.13%   
Garofalo Health Care fundamentals help investors to digest information that contributes to Garofalo Health's financial success or failures. It also enables traders to predict the movement of Garofalo Stock. The fundamental analysis module provides a way to measure Garofalo Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Garofalo Health stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Garofalo Health Care Company Profit Margin Analysis

Garofalo Health's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Garofalo Health Profit Margin

    
  0.07 %  
Most of Garofalo Health's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Garofalo Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Garofalo Health Care has a Profit Margin of 0.0705%. This is 100.63% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The profit margin for all Germany stocks is 105.55% lower than that of the firm.

Garofalo Health Care Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Garofalo Health's current stock value. Our valuation model uses many indicators to compare Garofalo Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Garofalo Health competition to find correlations between indicators driving Garofalo Health's intrinsic value. More Info.
Garofalo Health Care is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.50  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Garofalo Health Care is roughly  2.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Garofalo Health's earnings, one of the primary drivers of an investment's value.

Garofalo Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Garofalo Health's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Garofalo Health could also be used in its relative valuation, which is a method of valuing Garofalo Health by comparing valuation metrics of similar companies.
Garofalo Health is currently under evaluation in profit margin category among its peers.

Garofalo Fundamentals

About Garofalo Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Garofalo Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Garofalo Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Garofalo Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Garofalo Health Care S.p.A. operates healthcare centers in Italy. It operates 19 healthcare facilities located in Piedmont, Veneto, Tuscany, Emilia-Romagna, Lazio, and Liguria. GAROFALO HEALTH operates under Medical Care Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1187 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Garofalo Stock

Garofalo Health financial ratios help investors to determine whether Garofalo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Garofalo with respect to the benefits of owning Garofalo Health security.